Hippocratic AI, a healthcare startup specializing in patient-facing AI agents, has raised $141 million in a Series B funding round led by Kleiner Perkins, bringing its valuation to $1.64 billion. Existing investors, including General Catalyst, Andreessen Horowitz (a16z), and NVIDIA, also participated. The company’s AI solutions address critical healthcare workforce shortages by handling non-diagnostic, patient-facing tasks such as pre-operative procedures, remote patient monitoring, and appointment preparation. Unlike many healthcare AI companies focused on administrative efficiency, Hippocratic AI prioritizes enhancing patient care and accessibility.
Founded less than two years ago, Hippocratic AI has experienced rapid growth, securing contracts with 23 health systems and insurers in 2024. The new funding will support the company’s product expansion into additional healthcare markets and its international growth to meet global demand. This investment follows a $53 million Series A round nine months ago and a $17 million funding injection from NVIDIA five months later. With strong financial backing and innovative AI-driven solutions, Hippocratic AI is poised to transform healthcare delivery and bridge gaps in care accessibility and workforce capacity.